Impact of Stress First Aid for Workers in Substance Misuse Settings
ConditionOccupational Health
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorUniversity of Texas at Austin
About this trial
Test the effectiveness of SFA adapted for the substance use outreach workforce compared to a no treatment control condition on social-support and burnout of HRWs in a cluster-randomized hybrid type I trial.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
At least 18 years of age
In a paid or volunteer role as a substance use outreach worker or community health/outreach worker (whose work includes substance use outreach) with people who use drugs within TX, LA, AR, OK, NM and tribal areas
Able and willing to provide informed consent
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Stress First Aid (SFA)
BehavioralStress First Aid for the Substance Use Outreach Workforce is a 2-hour training and up to six virtual 30-minute monthly learning collaborative meetings.
Treatment groups
500 Participants
are divided into 2 treatment groupsGroup A: No TreatmentNo intervention 0 interventions
Group B: Stress First Aid (SFA)Experimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change from Baseline in the Mean Overall Burnout Assessed by the Copenhagen Burnout Inventory at 2 Months
A 19-item, 5-point Likert type scale, where a higher score is a worse outcome. Minimum score of 0, maximum score of 100.
Time frame
From enrollment to 2 months after the intervention training2
Change from Baseline in the Mean Overall Social Support Assessed by the Job Content Questionnaire Social Support Sub-Scale at 2 Months
An 8-item; 4-point Likert-type scale, where a higher score is a better outcome. Minimum score of 8, maximum score of 40.
Time frame
From enrollment to 2 months after the intervention trainingSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Texas at Austin
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov